ABC | Volume 111, Nº2, Agosto 2018

Posicionamento 1º Posicionamento Brasileiro sobre o Impacto dos Distúrbios de Sono nas Doenças Cardiovasculares da Sociedade Brasileira de Cardiologia Arq Bras Cardiol. 2018; 111(2):290-340 422. Theorell-Haglöw J, Berglund L, Berne C, Lindberg E. Both habitual short sleepers and long sleepers are at greater risk of obesity: a population-based 10-year follow-up in women. Sleep Med. 2014;15(10):1204-11. doi: 10.1016/j.sleep.2014.02.014. 423. Spiegel K, Leproult R, Cauter EV. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435-9. doi: 10.1016/ S0140-6736(99)01376-8. 424. Shan Z, Ma H, Xie M, Yan P, Guo Y, Bao W, et al. Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2015;38(3):529-37. doi: 10.2337/dc14-2073. 425. King CR, Knutson KL, Rathouz PJ, Sidney S, Liu K, Lauderdale DS. Short sleep duration and incident coronary artery calcification. JAMA. 2008;300(24):2859-66. doi: 10.1001/jama.2008.867 426. Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, et al. Aprospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 2003;163(2):205-9. PMID: 12546611. 427. Ikehara S, IsoH, Date C, Kikuchi S, Watanabe Y, Wada Y, et al. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep. 2009;32(3):295-301. PMID: 19294949. 428. Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review andmeta-analysis of prospective studies. Eur Heart J. 2011;32(12):1484-92. doi: 10.1093/ eurheartj/ehr007. 429. Méier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, et al. Effect of sleep loss on C-reative protein, an inflammatory marker of cardiovascular risk. J AmColl Cardiol. 2004;43(4):678-83. doi: 10.1016/j. jacc.2003.07.050. 430. Miller MA, Cappuccio FP. Biomarkers of cardiovascular risk in sleep- deprived people. J Hum Hypertens. 2013;27(10):583-8. doi: 10.1038/ jhh.2013.27. 431. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA); 2013. 432. Ohayon MM, Reynolds CF 3rd. Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD). Sleep Med. 2009;10(9):952-60. doi: 10.1016/j.sleep.2009.07.008. Erratum in: Sleep Med. 2010;11(2):227. 433. Fernandez-Mendoza J, Calhoun SL, Bixler EO, Karataraki M, Liao D, Vela-Bueno A, et al. Sleep misperception and chronic insomnia in the general population: role of objective sleep duration and psychological profiles. PsychosomMed. 2011;73(1):88-97. doi: 10.1097/ PSY.0b013e3181fe365a. 434. Fernandez-Mendoza J, Baker JH, Vgontzas AN, Gaines J, Liao D, Bixler EO. Insomnia symptoms with objective short sleep duration are associated with systemic inflammation in adolescents. Brain Behav Immun. 2017 Mar;61:110-6. doi: 10.1016/j.bbi.2016.12.026. 435. Lin CL, Tsai YH, Yeh MC. The relationship between insomnia with short sleep duration is associated with hypercholesterolemia: a cross-sectional study. J Adv Nurs. 2016;72(2):339-47. doi: 10.1111/jan.12844. 436. Cespedes EM, Dudley KA, Sotres-Alvarez D, Zee PC, Daviglus ML, Shah NA, et al. Joint associations of insomnia and sleep duration with prevalent diabetes: theHispanic CommunityHealth Study/Study of Latinos (HCHS/ SOL). J Diabetes. 2016;8(3):387-97. doi: 10.1111/1753-0407.12308. 437. Bathgate CJ, Edinger JD,Wyatt JK, Krystal AD. Objective but not subjective short sleep duration associated with increased risk for hypertension in individuals with insomnia. Sleep. 2016;39(5):1037-45. doi: 10.5665/ sleep.5748. 438. Fernandez-Mendoza J, Vgontzas AN, Liao D, Shaffer ML, Vela-Bueno A, Basta M, et al. Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension. 2012;60(4):929-35. doi: 10.1161/HYPERTENSIONAHA.112.193268 439. Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev. 2013;17(4):241-54. doi: 10.1016/j. smrv.2012.09.005. 440. Chien KL, Chen PC, Hsu HC, Su TC, Sung FC, Chen MF, et al. Habitual sleep duration and insomnia and the risk of cardiovascular events and all-cause death: report from a community-based cohort. Sleep. 2010;33(2):177-84. PMID: 20175401. 441. Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Basta M, et al. Insomnia with short sleep duration and mortality: the Penn State cohort. Sleep. 2010;33(9):1159-64. PMID: 20857861. 442. Bathgate CJ, Edinger JD, Krystal AD. Insomnia patients with objective short sleep duration have a blunted response to cognitive behavioral therapy for insomnia. Sleep. 2017 Jan 1;40(1). doi: 10.1093/sleep/zsw012. 443. Javaheri S, Redline S. Insomnia and risk of cardiovascular disease. Chest. 2017;152(2):435-44. doi: 10.1016/j.chest.2017.01.026. 444. Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol. 2014;21(1):57-64. doi: 10.1177/2047487312460020. 445. Li M, Zhang XW, Hou WS, Tang ZY. Insomnia and risk of cardiovascular disease:ameta-analysisofcohortstudies. Int JCardiol.2014;176(3):1044- 7. doi: 10.1016/j.ijcard.2014.07.284. 446. Parthasarathy S, Vasquez MM, HalonenM, Bootzin R, Quan SF, Martinez FD, et al. Persistent insomnia is associated with mortality risk. Am J Med. 2015;128(3):268-75. doi: 10.1016/j.amjmed.2014.10.015. 447. American Academy of SleepMedicine. International classification of sleep disorders. diagnostic and coding manual. 2nd ed. Westchester, IL; 2005. 448. DauvilliersY,BilliardM,Montplaisir J.Clinicalaspectsandpathophysiology of narcolepsy. Clin Neurophysiol. 2003;114(11):2000-17. PMID: 14580598. 449. Plazzi G, Ferri R, Antelmi E, Bayard S, Franceschini C, Cosentino FI, et al. Restless legs syndrome is frequent in narcolepsy with cataplexy patients. Sleep. 2010;33(5):689-94. PMID: 20469811. 450. LongstrethWT Jr, Koepsell TD, Ton TG, Hendrickson AF, van Belle G. The epidemiology of narcolepsy. Sleep. 2007;30(1):13-26. PMID: 17310860. 451. Silber MH, Krahn LE, Olson EJ, Pankratz VS. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep. 2002;25(2):197-202. PMID: 11902429. 452. Sachs C, Kaijser L. Autonomic regulation of cardiopulmonary functions in sleep apnea syndrome and narcolepsy. Sleep. 1982;5(3):227-38. PMID: 6813932. 453. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet. 2007;369(9560):499-511. doi: 10.1016/S0140-6736(07)60237-2. 454. Nishino S. Clinical and neurobiological aspects of narcolepsy. SleepMed. 2007;8(4):373-99. doi: 10.1016/j.sleep.2007.03.008. 455. Silvani A, Grimaldi D, Barletta G, Bastianini S, Vandi S, Pierangeli G, et al. Cardiovascular variability as a function of sleep–wake behaviour in narcolepsy with cataplexy. J Sleep Res. 2013;22(2):178-84. doi: 10.1111/ jsr.12007. 456. Grimaldi D, Calandra-Buonaura G, Provini F, Agati P, Pierangeli G, Franceschini C, et al. Abnormal sleep-cardiovascular system interaction in narcolepsy with cataplexy: effects of hypocretin deficiency in humans. Sleep. 2012;35(4):519-28. doi: 10.5665/sleep.1738. 457. Dauvilliers Y, Jaussent I, Krams B, Scholz S, Lado S, Levy P, et al. Non- dipping blood pressure profile in narcolepsy with cataplexy. PLoS One. 2012;7(6):e38977. doi: 10.1371/journal.pone.0038977. 458. Auger RR, Goodman SH, Silber MH, Krahn LE, Pankratz VS, Slocumb NL. Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: a case-control study. Sleep. 2005;28(6):667-72. PMID: 16477952. 338